Placebo to match ly, Eloralintide, Eloralintide, Eloralintide, Eloralintide
J3R-MC-YDAF
Phase 3 small_molecule active
Quick answer
Placebo to match ly, Eloralintide, Eloralintide, Eloralintide, Eloralintide for Obesity, Overweight is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Obesity, Overweight
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active